Treatment of Acute Venous Thromboembolism

被引：3
|
作者：
Nair, Sashi [1 ]
Garza, Nina [1 ]
George, Matt [2 ]
Kaatz, Scott [3 ]
机构：
[1] Henry Ford Hosp, Dept Med, 2799 West Grand Blvd, Detroit, MI 48202 USA
[2] Henry Ford West Bloomfield Hosp, Div Hosp Med, 6777 West Maple Rd, W Bloomfield, MI 48322 USA
[3] Henry Ford Hosp, Div Hosp Med, 2799 West Grand Blvd, Detroit, MI 48202 USA
来源：
MEDICAL CLINICS OF NORTH AMERICA | 2020年 / 104卷 / 04期
关键词：
Deep vein thrombosis; Pulmonary embolism; Anticoagulation; Thrombolytic; Risk stratification; ACUTE PULMONARY-EMBOLISM; DIRECT ORAL ANTICOAGULANTS; CATHETER-DIRECTED THROMBOLYSIS; INTENSITY WARFARIN THERAPY; VITAMIN-K ANTAGONISTS; DEEP-VEIN THROMBOSIS; ANTITHROMBOTIC THERAPY; EXTENDED TREATMENT; MULTICENTER TRIAL; INITIAL TREATMENT;
D O I：
10.1016/j.mcna.2020.03.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Acute venous thromboembolism is a common disease seen by nearly all hospitalists. The advent of low molecular weight heparin (LMWH) several decades ago ushered in the era of early hospital discharge and home treatment. More recently, the direct oral anticoagulants (DOACs) have further simplified outpatient treatment and some offer treatment without parenteral therapy. Use of DOACs for cancer-associated venous thromboembolism is emerging and is a welcome evolution of care to spare oncologic patients the burden of daily LMWH injections.
引用
收藏
页码：631 / +
页数：17
相关论文
共 50 条
  • [31] Update in the Treatment of Venous Thromboembolism
    Garcia, David A.
    Spyropoulos, Alex C.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 29 (01) : 40 - 46
  • [32] Duration of anticoagulation of venous thromboembolism
    Couturaud, Francis
    Meneveau, Nicolas
    Sevestre, Marie Antoinette
    Morange, Pierre-Emmanuel
    Jimenez, David
    PRESSE MEDICALE, 2024, 53 (03):
  • [33] Ten questions on Venous thromboembolism
    Giustozzi, Michela
    Agnelli, Giancarlo
    GIORNALE ITALIANO DI CARDIOLOGIA, 2019, 20 (11) : 611 - 618
  • [34] Venous thromboembolism: current management
    Stevens, Hannah
    Huyen Tran
    Gibbs, Harry
    AUSTRALIAN PRESCRIBER, 2019, 42 (04) : 123 - 126
  • [35] Current Venous Thromboembolism Management and Outcomes in Japan - Nationwide The Japan Venous Thromboembolism Treatment Registry Observational Study
    Nakamura, Mashio
    Miyata, Tetsuro
    Ozeki, Yasushi
    Takayama, Morimasa
    Komori, Kimihiro
    Yamada, Norikazu
    Origasa, Hideki
    Satokawa, Hirono
    Maeda, Hideaki
    Tanabe, Nobuhiro
    Unno, Naoki
    Shibuya, Takashi
    Tanemoto, Kazuo
    Kondo, Katsuhiro
    Kojima, Tetsuhito
    CIRCULATION JOURNAL, 2014, 78 (03) : 708 - 717
  • [36] Use of the Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism
    Riva, Nicoletta
    Ageno, Walter
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (05) : 1035 - +
  • [37] What are the pharmacotherapy options for treating venous thromboembolism in cancer patients?
    Prandoni, Paolo
    Piovella, Chiara
    Filippi, Lucia
    Vedovetto, Valentina
    Valle, Fabio Dalla
    Piccioli, Andrea
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (06) : 799 - 807
  • [38] A treatment strategy using subcutaneous fondaparinux followed by oral rivaroxaban is effective for treating acute venous thromboembolism
    Kabuki, Takayuki
    Nakanishi, Rine
    Hisatake, Shinji
    Fujii, Takahiro
    Dobashi, Shintaro
    Wakakura, Shingo
    Kiuchi, Shunsuke
    Fujino, Tadashi
    Ikeda, Takanori
    JOURNAL OF CARDIOLOGY, 2017, 70 (1-2) : 163 - 168
  • [39] Management of venous thromboembolism - controversies and the future
    Keeling, David
    Alikhan, Raza
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (06) : 755 - 763
  • [40] Symptomatic endpoints for venous thromboembolism treatment
    Anderson, DR
    HAEMOSTASIS, 1998, 28 : 120 - 126
12345